Rybelsus Tablets 14mg (1 Month)

Rybelsus Tablets 14mg (1 Month)

Oral GLP-1 Receptor Agonist for Type 2 Diabetes Management

Rybelsus is an oral prescription medication containing Semaglutide. It is used to improve blood sugar (glucose) levels in adults with Type 2 diabetes. As a glucagon-like peptide-1 (GLP-1) receptor agonist, it works by increasing the amount of insulin your pancreas releases when your blood sugar is high and decreasing the amount of sugar your liver makes.

Key Therapeutic Actions

• Glycaemic Control: Helps to lower HbA1c levels when used alongside diet and exercise.

• Daily Oral Therapy: Offers the benefits of a GLP-1 receptor agonist in a convenient once-daily tablet.

• Cardiovascular Support: Supports metabolic health in patients with established cardiovascular disease.

How to Use (Strict Administration Required)

The absorption of Rybelsus is highly sensitive to food and drink. To ensure effectiveness:

1. Timing: Take your tablet first thing in the morning on an empty stomach.

2. Water Only: Swallow the tablet whole with a small sip of plain water (no more than 120ml).

3. The 30-Minute Rule: Wait at least 30 minutes before eating, drinking anything else, or taking any other oral medications.

4. Integrity: Do not crush, split, or chew the tablet.

 Critical Safety Information

• Thyroid Warning: Tell your doctor if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

• Pancreatitis: If you experience severe and persistent stomach pain (which may reach through to your back) with or without vomiting, stop use and seek immediate medical attention.

• Not for Type 1: Rybelsus is not for use in patients with Type 1 diabetes or for the treatment of diabetic ketoacidosis.

• Dehydration: Nausea and diarrhoea can lead to dehydration. Ensure you drink plenty of fluids, especially when first starting or increasing your dose.

Possible Side Effects

• Very Common: Nausea, stomach pain, diarrhoea, and decreased appetite. These are most common during the dose-escalation phase and typically subside.

• Hypoglycaemia: If used with a sulphonylurea or insulin, your risk of low blood sugar may increase. Your doctor may adjust your other medications.

• Vision Changes: Inform your doctor if you notice any changes in your vision during treatment.

Composition & Storage

• Active Ingredient: Semaglutide 14mg.

• Absorption Enhancer: Contains SNAC (salcaprozate sodium) to help the medicine enter the bloodstream.

• Storage: Store in the original blister pack to protect from light and moisture. Store below 30°C.

• Important: Only remove the tablet from the blister pack immediately before taking it.